Organ preservation has been of major importance ever since transplantation developed into a global clinical activity. The relatively simple procedures were developed on a basic comprehension of low-temperature biology as related to organs outside the body. In the past decade, there has been a significant increase in knowledge of the sequelae of effects in preserved organs, and how dynamic intervention by perfusion can be used to mitigate injury and improve the quality of the donated organs. The present review focuses on (1) new information about the cell and molecular events impacting on ischemia/reperfusion injury during organ preservation, (2) strategies which use varied compositions and additives in organ preservation solutions to deal with these, (3) clear definitions of the developing protocols for dynamic organ perfusion preservation, (4) information on how the choice of perfusion solutions can impact on desired attributes of dynamic organ perfusion, and (5) summary and future horizons.
Introduction
Organ transplantation has developed over the past 60 years from what could be considered a surgical research technique available to only a handful of patients into a globally accepted treatment for end organ failure [1] [2] [3] . Many advances have been made in the clinical understanding of the essential elements for success, including patient management, specialized surgical intervention, immunosuppression, and, of note in this review, organ preservation, which has been considered to be the supply line for clinical transplantation [4, 5] . In this review we will consider (1) the history and current applications of organ preservation, (2) new achievements in our understanding of the ischemic injury which can result during donor organ retrieval and how these might be mitigated using new additives to organ preservation solutions (OPS), and (3) the scientific basis for machine perfusion of donor organs, which is becoming a new focus in the organ preservation pathway. and the potentially harmful functional consequences of hypoxia once the organ has been deprived of normal blood supply. Cooling is an intuitive way to reduce metabolic demand, but applying it to organs ex vivo and in a ways which could be readily reversed on transplantation, across a range of abdominal and cardiothoracic organs, required considerable research and development. Early in the 20th century, attempts to produce artificial circulatory support to perfuse organs in vitro were developed in systems such as the kidney and liver by simple syringe methods and provided detailed information on the physiology of organ function [6] . In parallel, efforts were made to formulate synthetic perfusate solutions of electrolytes, solutes, vitamins, etc. capable of replacing blood in some respects [7, 8] . At the same time, information on the impact of hypothermia on organ function was also starting to be recorded [9] .
Early investigations on the use of hypothermia in organs subsequently transplanted were undertaken by Calne et al. [10] in the kidney. They investigated the relative merits of cooling kidneys by simple surface cooling or by perfusion of the renal artery with cooled heparinized blood and concluded that vascular flush perfusion was the preferred method of cooling. However, the use of diluted blood in this way still led to problems with early vascular stasis in the grafted kidney, promoting the search for better OPS, preferably synthetic solutions which could be reliably manufactured and sterilized to be available at short notice as required [11] . The OPS described by Collins et al. [12] was designed to mimic, in a simple fashion, the intracellular electrolyte balance, which was in turn based on an understanding of the ongoing changes in cells during hypothermic and hypoxic exposure. This solution became a mainstay of clinical organ preservation for almost two decades. Successful renal preservation was achieved for up to 1 day, long enough to allow transplant tissue matching and sharing of organs over a wide geographic area. Alongside these approaches, proponents of continuous hypothermic machine perfusion (HMP) continued to develop methods for use of bloodless perfusates in oxygenated low-temperature perfusion across a range of organs [13] [14] [15] . However, the logistics and reliability of the available equipment meant that gradually, flush cooling and ice storage with synthetic OPS became the most widely used preservation method and allowed techniques for multiple organ retrievals from a single donor to be developed using the so-called "flexible techniques" [16] in which all organs designated for transplantation are cooled in situ, rapidly removed in a bloodless field, and further dissected on a back table. Following on from Collins et al.'s [12] work, other formulations of commercially produced OPS came forward based on progressive research into organ cold hypoxia. For example, Ross et al. [17] developed an intracellular mimic based on citrate as the major anion. Later, Belzer et al. [18] proposed another formulation with improved buffering and anion composition, which became known as the University of Wisconsin (UW) solution and remains in wide clinical application today. These will be discussed in greater detail below.
Since that time, it will be apparent that there is a fundamental choice to be made in organ preservation; whether to sustain ex vivo circulation by HMP and to supply oxygen to sustain low-level oxidative organ metabolism, or whether to use OPS to protect against the progressive hypoxia in the isolated organ during static cold storage (SCS) whilst using inexpensive and readily transportable ice storage of the cold-flushed, sterile-packed organ. For many years, the choice of SCS has dominated clinical organ preservation, but currently there is growing interest once more in dynamic intervention by organ perfusion, driven by many factors, including changing donor demographics and the need to utilize all available organs for transplantation to meet the rising clinical need. Recent publications continue to debate these issues [19] [20] [21] .
Ischemia/Reperfusion Injury as a Major Focus in Organ Preservation

Regulatory Mechanisms of Cellular Injury
Historically, the development of effective OPS has always been accompanied by a deep focus on the mechanisms and strategies to attenuate ischemia/reperfusion (I/R)-induced cellular injury. Preservation methods and choice of solutions have an impact on organs across a diverse range of molecular response, thus providing crucial information about the timelines of processes to develop injuries and their physicochemical variations in relation to the OPS used (see The Central Role of OPS in Organ Preservation for more detail). In this case, special importance is given to the cellular and intracellular machineries under the pathological conditions of hypoxia. On the one hand, the cellular compartments are compromised by the duration of the ischemic period, donor age, trauma, existing infection, or other factors. On other hand, cellular heterogeneity, reflecting the organ complexity, influences profound imbalances in metabolism during I/R. The studies performed over the last three decades using isolated cell systems have significantly broadened our understanding of I/R, yet many pathophysiological aspects of the intercellular cooperation in tissue are still far from a unified understanding.
Experiments with I/R clearly demonstrated that severity of the injury after reperfusion directly correlated with the interval of ischemia. Hence, restoration of blood supply to the organ in the shortest possible time is essential. The general paradigm of the cellular reactions upon I/R may reflect a picture of the sterile inflammation phenomenon [22] . This inflammation is predominated by the sentinel pattern recognition receptor systems [23] and involves complex reactions such as reactive oxygen species (ROS), leukocyte and platelet sequestration to the endothelium [24] , transmigration of neutrophils, and the release of endogenous inflammatory mediators.
Microvascular Dysfunction and Immune Cell Response in I/R-Induced Inflammation
Microvascular dysfunction is an early factor in the pathogenesis of I/R injury (IRI) and forms the basis for elaborating the underlying mechanisms of this pathological process. This type of injury is most frequently associated with SCS. Studies of rat liver transplantation demonstrated the crucial role of the onset of blood cessation in the development of IRI, bringing into question early microvascular impairment as a prognostic parameter for the assessment of early graft function in clinical practice [25] . It has been demonstrated that even a short duration of 20 min warm ischemia in the liver results in decreased sinusoidal diameter, which is associated with "plugging" of leukocytes upon reperfusion, as well as sinusoidal obstruction caused by endothelial cell swelling [26] . In contrast, cold ischemia protects from hepatic microcirculatory perfusion failure after 90 min of lobar ischemia [27] . However, prolongation of hypothermia to 24 h significantly reduced sinusoidal perfusion rates [28] .
The mechanical and functional basis of microvascular reflow impairment after I/R was attributed to a series of interrelated events which share common characteristics in different organs. These include interstitial edema formation due to increased capillary permeability [29] when interstitial tissue pressure may physically compress the capillaries and microvascular spasm [30] caused by vasoactive substances.
Some preservation solution compositions impart a vasoactive property and affect tissue microcirculation during I/R. For instance, flushing the organ with low-potassium medium prior to preservation may protect microvessels from the adverse effects of cold storage and improve reperfusion after transplantation in situations where vasoconstriction might be caused by a high potassium content in the OPS. Liver flushing with the OPS histidine-tryptophan-ketoglutarate (HTK), which is known to be low in K + ions, prior to organ storage in UW solution improved hepatic microcirculation and reduced sinusoidal leukostasis [31] . Another approach shows that a rinse with the low-potassium solution after cold storage prior to organ implementation substantially diminished postoperative sinusoidal endothelial cell damage. It was concluded that the synergistic action of UW solution as OPS and the Carolina Rinse solution as rinsing vehicle was more beneficial for the vascular bed than each solution used separately [25, 32] . This finding provides some arguments in favor of removal of high-K + -containing solution before transplantation.
The "no-reflow" phenomenon in I/R is attributed to leukocyte plugging of the capillary lumens. Leukocytes are large and stiff cells which adhere to vascular endothelium and are more likely to become captured in capillaries, thereby obstructing luminal flow. Heart and kidney I/R models have demonstrated presence of leukocytes in a very high proportion in occluded capillaries. Additionally, the impact of hemodynamic forces upon reperfusion has also been implicated in the adhesion of leukocytes and further impairment of endothelial cells [33] . Perfusing the organ with hypertonic saline-dextran solution decreased endothelial cell swelling and inhibited neutrophil adhesion [34] , which can form part of therapeutic strategies to restore the normal capillary network [35] .
Discovering the role of gas mediators such as hydrogen sulfide (H 2 S), carbon monoxide (CO), and nitric oxide (NO) is regarded as a milestone in organ preservation and transplantation, and they are promisingly considered to be effective in the protection of the endothelium during organ storage. In particular, across the wide spectrum of signaling functions, these molecules came out to be potent anti-platelet adhesion and anti-inflammatory substances [29] , modulating the relaxation of stellate cells and improving the microcirculation of hepatic sinusoids [36] . It has recently been shown that endogenous H 2 S regulates many physiological processes, including vascular tone. Additionally, H 2 S was shown to interact with NO and form another potent vasorelaxant -nitroxyl [37] .
After leukocyte plugging, the adhesion cascade is another major molecular process of leukocyte recruitment during an inflammatory response in I/R. Leukocyte adhesion with postcapillary venular endothelium initiates by forming loose contacts (leukocyte rolling). The sticking of leukocytes to the endothelium is mediated primarily by transmembrane adhesion receptors -integrins, selectins, vascular cell adhesion molecule-1 (VCAM-1), intercellular adhesion molecule-1 (ICAM-1) -responsible for adhesion of cells and extracellular matrix and rolling. Recent studies have challenged the potential therapeutic significance of α4β1 integrin receptors (β1 integrin family), which binds with the connecting segment-1 (CS-1), a V region of fibronectin. The latter is a key extracellular protein expressed by sinusoidal endothelial cells in the early beginning of liver ischemia [38] . Blockage of α4β1-CS-1 region interaction with a specific peptide resulted in an increase in survival (from 40 to 100%) for 14 days after orthotopic liver transplantation as well as a reduction in TNF-α and IFN-γ expression as well as T-lymphocyte and leukocyte sequestration [39] .
Interactions between integrin receptors [40] and other adhesion molecules like VCAM-1, ICAM-1, and P-and DOI: 10.1159/000499610 E-selectins reveal a complicated and tissue-specific regulatory mechanism of leukocyte adhesion and extravasation. For instance, in comparison with lungs and heart, liver sinusoidal endothelium neutrophil tethering and "crawling" does not exhibit strict dependency of P-selectin/integrin assistance [41, 42] . However, neutrophil extravasation from the hepatic microcirculation into the parenchyma is facilitated by β2 and β1 integrins [43] , showing their direct contribution to ligands/counterreceptor participation in neutrophil transmigration. Interestingly, neutrophil extravasation through pericyte gaps into the parenchyma corresponds to regions with low contents of specific matrix proteins in the basement membrane. It could be hypothesized that the cold-induced decrease in endothelial junctional proteins such as F-actin, occludin, and VE-cadherin [44] may be responsible not only for the development of organ edema, but also for extravasation of neutrophils [45] . The influence of OPS on the expression of adhesion molecules could provide additional information in relation to recruitment of immune cells in inflammation during organ reperfusion. Comparative studies of HTK and UW solutions have shown much lower expression of P-selectin in the UW solution group, which demonstrates a significant benefit over HTK [46] .
Kupffer Cells and Macrophages in I/R
Kupffer cells are resident macrophages of hepatic sinusoids which are well known to be a powerful source of ROS, proteases, platelet activating factor, and cytokines during I/R. Activated Kupffer cells begin to produce proinflammatory cytokines, such as IL-1β and TNF-α, promoting the migration of neutrophils and CD4+ T lymphocytes with the subsequent development of inflammation in the parenchyma.
A growing body of data demonstrate that Kupffer cells are an important participant in the development of sterile inflammation mediated via Toll-like receptors (TLRs), which are a significant part of signaling pathways in sentinel cells. In contrast to pathogen-activated inflammation, TLRs are triggered by intracellular factors and fragments of extracellular matrix, named damage-associated molecular patterns (DAMPs), which are released from ischemically injured cells. DAMPs are recognized by the innate immune cells (macrophages, leukocytes, and dendritic cells) as well as vascular cells (fibroblasts and endothelial cells) to promote proinflammatory and profibrotic pathways [47] .
DAMPs include high-mobility group box-1 (HMGB-1), DNA of mitochondria and nucleus, purine metabolites, hyaluronan, and others. Despite the fact that the precise regulatory mechanism of Kupffer cell activation is yet to be fully unveiled, the current experimental data amply demonstrate interrelation between Kupffer cell/TLR ligation and subsequent complement activation, ROS formation, neutrophil recruitment, and platelet aggregation. The prominent role of TLR-4 triggering was confirmed in orthotopic liver transplantation models. Knockout mice deficient in liver TLR-4 had significantly lower liver expression of TNF-α, myeloperoxidase, aspartate aminotransferase, and CD4+ T cell infiltration [48, 49] . In a model of renal inflammation, ischemia-induced synthesis of TLR-2 and TLR-4 was substantially attenuated by inhibition of cytokine production with IFN-γ and TNF-α antibodies pretreatment. Similarly, inhibition of HMGB-1 -a nuclear and cytoplasmic ligand for TLR-2 and TLR-4 -decreased liver injury after cold storage and warm reperfusion [50] . This feature demonstrates the possible reciprocal regulation of pro-/anti-inflammatory factors and TLRs. Translation of inflammatory signals from TLR sustains feedback with target cells, resulting in suppression or activation of TLR expression. Future research in TLR function can provide a new basis for the development of ligand-receptor-mediated drugs for limiting IRI.
Kupffer and other immune cells in the inflammatory response caused by either warm or cold ischemia display high regulatory plasticity. In addition to ROS and cytokine production, there is evidence of the anti-inflammatory function of macrophages and Kupffer cells in hememediated injury. The scavenging of free hemoglobin from plasma is controlled by expression of the CD163 receptor on the surface of macrophages and monocytes. The endocytosis of hemoglobin via CD163-dependent internalization also stimulates the production of heme oxygenase-1 (HO-1) in macrophages followed by degradation of toxic heme [51, 52] . The HO-1-induced breakdown of hemoglobin is accompanied by CO release, known to possess strong anti-inflammatory and proangiogenic properties [53] . Another important aspect of Kupffer cells is the induction of apoptosis and removal of peripheral blood leukocytes during the tissue regenerative process [54] . Consequently, similar to other macrophages [55] , Kupffer cells play a dual role; in early reperfusion they intensify and at the later stages subside the inflammation to assist tissue healing.
The Role of Platelets in Organ IRI
Platelet aggregation during hemostasis is regularly described as a privileging process of blood coagulation in the vascular defense against trauma. However, the decrease in platelet numbers due to their sequestration in organs after cold storage has apparently been considered a potential risk in organ transplantation. A closer look at this problem shows a lack of evidence for platelet adhesion to vascular endothelium [56] . clot formations or vessel occlusions observed. Therefore, it has been concluded that platelet-induced endothelial cell injury is probably not related to their procoagulant properties.
During past decades, the information about the role of platelets in IRI has been revised and supplemented. There is compelling evidence to suggest that platelets participate in endothelial cell adhesion in cooperation with neutrophils and lymphocytes to initiate innate immune responses under different pathological conditions. Activated platelets were shown to stimulate neutrophil/macrophage ROS production, control endothelial permeability, and promote neutrophil infiltration. The hallmark of platelet-endothelial cell adhesion is the formation of a matrix which includes neutrophil extracellular traps, and P-selectin mediated leukocyte binding [57] that predominantly has negative consequences for the transplant functional state.
Activated platelets express a range of adhesion receptors, such as P-selectin (CD62P), TGF-β, PF4 (CXCL4), IL-1β, and others, which predispose their interactions with immune cells, endothelial cells, and adhesion molecules. The list of platelet receptors as well as a sequence of events, including the mechanisms for their recruitment, is constantly being updated [58] . The recent finding of HMGB-1 protein in platelets shows their importance in the regulation of neutrophil extracellular trap formation and thrombosis [59] mediated via TLRs.
These varieties of signal transduction clearly encompass far more than the hemostatic or inflammatory functions of platelets and also expand the horizon for endeavors in the treatment of organ IRI. For example, the translational studies of regeneration and repair after I/R suggest the participation of platelets in liver recovery after partial hepatectomy. The repairing effect of platelets could possibly be explained by contact or even uptake of cells by hepatocytes [60] and the release of insulin-like growth factor-1 (IGF-1), hepatocyte growth factor (HGF), vascular endothelial growth factor (VEGF), and serotonin from platelets, which together can promote hepatocyte proliferation [61] . Yet, further research is required to fully clarify the platelet regenerative potential following organ I/R.
It may be expected that platelet aggregation and adhesion originates not only from pathological changes in themselves. Cold-induced alterations of the microvascular environment may readily contribute to platelet activation. The direct contact with collagen of exposed subendothelial extracellular matrix, ADP release from damaged cells or due to inhibition of T-lymphocyte ectonucleotidase, and leukocyte cytokine production may be considered in the frontline of platelet adhesion and aggregation [62] . The balance between ROS and NO production serves as an alternative regulatory mechanism of platelet adhesion. It is extensively recognized that production of NO by endothelial cells prevents platelets adhesion. On the contrary, superoxide anion (O 2 -) induces vascular adhesion of platelets and leukocytes. It is intriguing that NO can scavenge O 2 -much faster than superoxide dismutase does. Therefore, O 2 -overproduction after I/R may increasingly surpass NO bioavailability. Additionally, as was reported recently [63] , modifications of endothelial NO synthase (eNOS), due to the loss of the enzyme cofactor tetrahydrobiopterin or/and eNOS uncoupling, makes production of ROS instead of NO possible.
Taken together, it is still controversial which of the factors predominate in platelet activation response. Understanding of the synergistic ways of intercellular regulation after cold storage will be essential for prevention of IRI [57] .
The Role of Endothelial Glycocalyx in IRI
Degradation of the endothelial glycocalyx (GCX) has been implicated in several disease processes including sepsis, trauma, and IRI [64] . The GCX is a thin (60-570 nm), fragile, and ubiquitously expressed "hair-like" layer on the luminal surface of all blood vessels and is responsible for vital physiological functions of the endothelium. This layer is composed of proteoglycan core proteins (such as syndecans and glypicans) with a transmembrane domain on the endothelial surface which are crosslinked with highly sulphated glycosaminoglycan chains (dermatan sulphate, heparan sulphate, chondroitin sulphate). Together, these form a thin protective "mesh" on the endothelial surface which incorporates plasma proteins and several biologically active molecules including albumin, superoxide dismutase, xanthine oxidoreductase, lipoprotein lipase, cytokines, endogenous heparins, and regulators of the coagulation pathway [65] . In I/R, the GCX layer is disintegrated through enzymatic cleavage of the proteoglycan core proteins and glycosaminoglycan chains or direct oxidative stress by ROS [65] .
The complex mesh formed by the GCX is an important determinant of vascular permeability which acts as a sizeselective and charge-selective molecular sieve allowing small solutes (< 70 kDa) and water to pass but repels negatively charged plasma proteins to the center of the lumen. It is now widely accepted that the GCX is primarily responsible for the all-important semipermeability function of the endothelium [66] . The classical Starling principle of transvascular exchange has been revised to consider the presence of the GCX and more accurately describe fluid exchange in the microcirculation [66] . Disruption of the GCX in inflammatory states leads to vascular hyperpermeability and edema [67] .
The endothelial GCX acts, amongst other sensors, as a mechanotransductor to transmit flow-induced shear forces to the endothelial cytoskeleton, triggering NO pro-DOI: 10.1159/000499610 duction, which plays an important protective role in the microcirculatory function in IRI. As well as a major determinant of vascular tone, NO has several endothelial protective functions through inhibiting intracellular calcium increase in platelets, thereby preventing activation and thrombosis as well as inhibiting monocyte proliferation and the transcription of leukocyte-binding adhesion molecules (such as VCAM-1). Defective endothelial mechanosensing results in a reduction in eNOS activity causing decreased NO release and antioxidant defense. Liver steatosis is a major risk factor for graft failure in liver transplantation mainly due to microcirculatory disturbances. It has recently been demonstrated that steatotic livers have a poor response to shear stress, which is an important function of the GCX. Steatotic livers had a reduced level of eNOS activity and NO production as well as decreased Kruppel-like factor 2 expression under subnormothermic perfusion [68] . In a recent study of steatotic rat liver preservation, it was shown that Institut Georges Lopez-1 (IGL-1 ® ) preservation solution produced less GCX injury over HTK, which was associated with significantly reduced hepatocyte damage and higher NO production after 24 h of SCS [69] . Therapeutic strategies in GCX protection during organ preservation could potentially enhance the organ viability of marginal donors and reduce the severity of IRI.
The GCX also provides vascular protection by "shielding" the endothelial cells from interaction with circulating platelets and leukocytes -the so-called "immune camouflage" effect. The projections of cell surface adhesion molecules such as selectins (platelet endothelial cell adhesion molecule, VCAM), ICAM, and integrins (CD11/ CD18) are physically shorter than the thickness of a healthy GCX in vessels [70] , which inhibits firm adhesion of platelets and leukocytes. Reduced platelet and leukocyte adhesion has been demonstrated with GCX protection in I/R models of isolated guinea pig hearts [71, 72] . Furthermore, degradation of the GCX in cultured endothelial cells under flow has been shown to induce a proinflammatory phenotype and to increase leukocyte adhesion [73] . Shedding of the GCX layer leads to a vicious cycle of inflammation in two ways. First, a reduction in GCX thickness leaves cell surface adhesion molecules exposed to circulating inflammatory cells and platelets, In a physiological state, the healthy GCX maintains normal vascular permeability, response to shear stress, and NO production. Early events in IRI include activation of Kupffer cells and ROS and cytokine production which cause direct or indirect damage to the endothelial GCX in the hepatic sinusoid. This results in increased platelet and leukocyte adhesion as well as a loss of vascular permeability leading to tissue edema. The GCX degradation products act as DAMPs, further exacerbating the inflammatory response with the release of cytokines and recruitment of inflammatory cells (neutrophils, macrophages, CD4+, and natural killer T cells) to the liver after reperfusion. The combined effects of tissue edema, microvascular congestion from platelet and leukocyte aggregation, and direct effect of inflammatory cells lead to liver sinusoidal and hepatocyte cell death. DAMPs, damage-associated molecular patterns; GCX, glycocalyx; IRI, ischemia/reperfusion injury; NO, nitric oxide; ROS, reactive oxygen species.
which may further facilitate ligand-receptor interactions leading to release of cytokines, matrix metalloproteases, and ROS which cause further GCX shedding [74] . Second, the inflammatory response can be exacerbated by the circulating degraded fragments of the GCX which have been characterized as DAMPs resulting in cytokine release when binding to TLR receptors on macrophages, dendritic cells, and endothelial cells [75] (Fig. 1) .
There is a significant rise in GCX shed products at reperfusion [76] during liver transplantation. It is not clear whether the substantial rise in the recipient circulating GCX products is due to flushing of the shed GCX from the donor liver that has already occurred in preservation or secondary to GCX shedding in the recipient due to reperfusion injury. Given its vital physiological functions, GCX damage could be responsible for several posttransplant complications. A recent large clinical study of patients admitted to the intensive care unit with sepsis showed that GCX shedding is more severe in patients with acute respiratory distress syndrome and multiple organ failure [77] . Significant GCX disruption in patients with hemorrhagic shock secondary to trauma is associated with the development of coagulopathy and increased mortality [78] . Prevention of local and systemic GCX disruption could potentially provide a novel unifying target to markedly reduce many of the direct and remote complications that arise as a result of IRI in the recipient, as well as provide opportunities for donor organ resuscitation during organ preservation.
The Central Role of OPS in Organ Preservation
In reality, the choice of OPS, and the science underpinning their development, are central to organ preservation, whether HMP or SCS are to be used [79] . Ischemia comes at a huge cost to all cells with aerobic metabolism, resulting in cellular injury via a complex and interconnected chain of numerous failing mechanisms essential for homeostasis culminating in cell death. Although cooling initially suppresses the metabolic rate, prolonged cold ischemia leads to depletion of cellular adenosine triphosphate (ATP) and accelerated glycolysis as well as lactic acid production. The accumulation of adenine breakdown products such as hypoxanthine initiate oxygen free radical production. Cellular acidosis interrupts pH-and energydependent cellular processes including transmembrane ion pumps (Na/K + and Ca 2+ ) which ultimately lead to influx of ions (Na + and Cl -) and water, causing loss of membrane potential and progressive cell swelling. Cell membrane injury occurs as a result of the release of lysosomal enzymes in response to intracellular acidosis and direct oxidative damage from free radicals. The activation of harmful proteases and phospholipidases caused by increasing levels of intracellular Ca 2+ due to membrane pump failure results in mitochondrial membrane injury with the appearance of mitochondrial permeability transition pores and the release of cytochrome C initiating cell death by apoptosis. The combined effect of increase in intracellular acidosis, activation of lysosomes, increasing levels of free Ca 2+ and Fe 2+ pools, and mitochondrial dysfunction contribute to a pro-oxidant environment which fuels ROS production and oxidative stress at early reperfusion. This basic understanding of the mechanisms of cell injury in cold preservation underpins the biochemical properties of preservation solutions which aim to target putative pathways mitigating the processes that lead to cell death. Hence, the constituents of OPS include impermeants and colloids to counteract water and electrolyte movement across cell membrane and prevent cell swelling, buffers to control changes in pH, antioxidants in the form of free radical scavengers, as well as nutrient precursors for ATP production and energy supply.
Early developments in OPS by Collins et al. [12] were based on impermeants with an "intracellular ion balance" through reversal of Na + /K + ratios found in plasma. This was later refined with the addition of glucose as an impermeant and removal of magnesium in the Collins C2 solution. The UW solution has a similar intracellular ion balance with the added benefit of a colloid (hydroxyethyl starch [HES] ) and pharmacological agents such as allopurinol (xanthine oxidase inhibitor), lactobionate and glutathione (free radical scavengers), as well as adenosine, a precursor for ATP production. IGL-1 ® solution is based largely on UW solution, but has an ionic balance close to the extracellular ratios of Na + /K + and a less viscous colloid (polyethylene glycol [PEG] ). The Celsior ® solution also has an extracellular ion balance and contains mannitol as well as histidine and reduced glutathione. HTK or Custodiol ® includes histidine and mannitol as impermeants with tryptophan and ketoglutarate as free radical scavengers and nutrient precursor, respectively. The TiProtec solution is based on the HTK formulation with a higher fractional ion content, α-ketoglutarate and aspartate as metabolic intermediates, and iron chelators to prevent iron-catalyzed oxidative stress.
Over the last decade, there has not been a great change in the composition of OPS. With the developments in the field of machine perfusion and organ resuscitation to improve the viability of marginal organs, there is a greater need for the development of new OPS.
New Areas of Focus in OPS
Mitochondria-Targeted Antioxidants Cold preservative solutions, described in a previous review [80] [19, 81] . There is no consensus about the optimal preservation solution up to now. To extend organ preservation time and maximize the yield of successful transplantations by improving the quality and function of organs, the composition of preservation solutions should be further optimized. A promising approach is inclusion of agents in preservation solutions with targeted mechanisms of action.
IRI is largely triggered by mechanisms that involve oxidative stress accompanied by accumulation of ROS. Mitochondria are considered one of the main producers of ROS during cold storage and reperfusion, and correspondently play a key role in IRI of organs. Hence, supplementation of preservation solutions with antioxidants directed at the mitochondria to prevent their dysfunction should minimize organ damage.
Antioxidants are common components of cold preservative solutions. In UW solution and IGL-1 ® , antioxidant activity is associated with a combination of allopurinol and glutathione. In IRI, allopurinol acts as an inhibitor of xanthine oxidase, suppresses the formation of ROS, and prevents mitochondrial membrane damage [82] . Glutathione, which is also a component of Celsior ® , is a wellknown natural antioxidant and cellular redox buffer. Due to its redox properties and participation in cellular redox homeostasis and signaling, glutathione is now also considered in therapeutics as a tool for stimuli-responsive drug delivery systems [83] . In Custodiol ® , the protection against oxidative stress is provided by tryptophan, which shows a high scavenging capacity [84] . Mannitol is a component of Celsior ® , Custodiol ® , and other solutions. Besides its osmotic effect, mannitol also plays an antioxidative role via upregulating the level of catalase which is otherwise decreased during oxidative stress [85] .
Rauen and de Groot [86] found a specific cold-induced increase in the small intracellular iron pool that is responsible for production of high reactive hydroxyl radicals and iron-oxygen species. Chelation of the iron by deferoxamine and lipophilic membrane-permeable LK-614 protects the myocardium and endothelium against irondependent hypothermic injury [87] . The authors have developed TiProtec, a new preservation solution, in which the role of antioxidants refers to iron chelators [88, 89] . TiProtec is the modified Custodiol ® (HTK) solution, which besides iron chelators (deferoxamine and LK-614) contains higher potassium concentration, amino acids (L-glycine and L-alanine) to inhibit hypoxic injury, arginine to increase NO supply, and N-acetyl-histidine instead of histidine as a buffer. It has been previously shown that replacing histidine with N-acetyl-histidine in Custodiol ® improved endothelial function in isolated rat aorta [87] . In several experimental systems, TiProtec has demonstrated promising results in preservation of hepatocytes, vascular endothelium, and smooth muscle cells after cold storage and a period of warm reperfusion. In a recent study [90] , iron chelators ensured protection via inhibition of mitochondrial permeability transition. Addition of iron chelators to cold preservation solutions resulted in increased oxygen consumption rate and regeneration of ATP as well as preserved attachment ability of isolated rat hepatocytes after returning to normothermic conditions.
The intensity of ROS formation depends on the potential on the inner mitochondrial membrane. Consequently, mitochondrial production of ROS is nonlinearly related to the value of the mitochondrial membrane potential, with significant increments at values exceeding 150 mV [91] . High values of the membrane potential are greatly dangerous, especially under conditions associated with oxidative stress. Mild uncoupling of oxidative phosphorylation is an approach to preventing hyperpolarization of the mitochondrial membrane. It has been proposed that the use of water-soluble uncoupler of oxidative phosphorylation 2,4-dinitrophenol (DNP) as a component of cold preservation solution will make it possible to lower oxidative injury of the liver [92] . Indeed, supplementation of sucrose-based cold solution with DNP resulted in decreasing ROS production in isolated livers after cold storage, uncoupler washout and, following normothermic reperfusion, preventing the inhibition of antioxidant enzyme activities, and improving morphology and bile secretion of the liver. The protective effect of DNP at the mitochondrial level involved a decrease in respiration rate in state 4, an increase in respiratory control index, and prevention of ATP depletion. Although the existence of high values of mitochondrial membrane potential during hypothermic storage is not documented, these encouraging results stimulate a search for agents with the capacity for selective regulation of ROS production by mitochondria.
One of the current strategies for delivery of mitochondrial antioxidants includes their conjugation to lipophilic cations. Lipophilic cations take advantage of mitochondrial membrane potential to facilitate their selective targeting and accumulation within the mitochondrial matrix. Lipophilic cation triphenylphosphonium (TPP + ) conjugated with derivatives of ubiquinol (MitoQ) or plastoquinone (SkQ) are the most advanced mitochondriatargeted antioxidants [93] . The level of TPP + -conjugated antioxidants in mitochondria can be more than 1,000-fold higher than its extracellular level [94] . Both mitochondria-targeted antioxidants, MitoQ and SkQ, are under intensive research and clinical trials, but they are not FDA-approved drugs so far. In animal models, MitoQ has demonstrated therapeutic potential in multiple diseases and pathologies: Alzheimer's disease, hypertension, type 1 diabetes, heart attack, sepsis, fatty liver disease, etc. [93] . The efficiency of SkQ has also been shown on numerous experimental models, including those accompanied by IRIs such as kidney and heart infarction and ischemic stroke [95] . SkQ has been used as a component of cold preservative solution for rat liver hypothermic storage [96] . Isolated rat livers were stored for 24 h at 4 ° C either with or without 1 μM SkQ followed by reperfusion for 60 min at 37 ° C. The presence of SkQ in the storage solution significantly decreased production of ROS in the liver during cold storage and reperfusion. The addition of SkQ to the cold preservation solution improved energy production function of the liver, demonstrated by increased respiratory control index of mitochondria and ATP levels. SkQ exhibited a positive effect on the liver secretory function and morphology after hypothermic storage, as estimated from enhanced bile flow rate during reperfusion and partial recovery of organ architecture as well as state of liver sinusoids and hepatocytes. These results demonstrate that mitochondria-targeted antioxidants are promising components of preservation solution for correction of IRI of isolated organs during cold storage.
Bioregulators
Improvement of organ survival by treatment with bioactive molecules which enable regulation and modulation of metabolic pathways is an attractive strategy in organ transplantation. Bioregulators may vary in size and nature. The properties of small-molecule bioregulators (CO, H 2 S, NO) are under intense study as discussed in Microvascular Dysfunction and Immune Cell Response in I/RInduced Inflammation and have been reviewed in relation to delivery in OPS [79] . Cytokines, growth factors, proteins, and other bioactive molecules can be obtained from different sources such as isolated cells, cellular extracts, and pharmaceutical products. Preclinical and clinical studies in the past decade have demonstrated the renoprotective properties of mesenchymal stem/stromal cells (MSCs) [97, 98] . MSCs are multipotent stem cells that can be isolated from a variety of adult or fetal stromal tissues and have a multilineage differentiation potential and the ability to repair damaged tissues and organs after transplantation. The therapeutic action of MSCs is associated with paracrine effects of secretomes, microvesicles, and exosomes, which are involved in the transfer of proteins and miRNA to neighboring cells. In total, MSCs secrete a lot of bioregulators such as IDO, TGF-α, TGF-β, prostaglandin E2, HGF, IL-6, IL-10, VEGF, and bFGF [99, 100] . These and other not yet identified bioregulators have diverse actions, such as modulating the local immune system, enhancing angiogenesis, preventing ROS production and cell apoptosis, as well as stimulating survival, proliferation, and differentiation of resident tissue cells [101] .
The implementation of MSC paracrine effects requires physiological conditions for synthesis and secretion of bioregulators. Therefore, for low-temperature preservation of organs, MSC-based therapy can be valuable on stages of preconditioning or after cold storage reperfusion. Thus, intratracheal MSC instillation after 8 h of cold storage (4 ° C) significantly decreased cold ischemia-induced lung injury [102] . The requirement for a source of viable MSCs is a limitation and raises the speculation as to the use of their conditioned media or natural mixture of bioregulators from other sources instead of MSCs themselves. It has been shown that supplementation of UW solution with trophic factor mixture (IGFs, epidermal growth factors and nerve growth factor, bactenecin, and substance P) substantially increased viability and reduced the production of hydrogen peroxide by tubular cells of dog kidneys after 3 days of cold storage [103] , protecting mitochondrial function and preventing apoptosis [104] . The presence of trophic factors enabled the prolongation of storage duration time (up to 6 days) and significantly improved posttransplant kidney function [105] . The efficiency of storage medium supplemented with such growth factors has also been shown in a pig allogenic liver transplantation model [106] .
The effects of bioregulators present in fetal tissue cytosol (FTC) of mesenchymal-mesodermal origin have been studied on a model of rat isolated liver. The choice of this source was based on high percentage of stem and progenitor cells and similarity with the microenvironment of MSCs. The unique composition of bioactive molecules and trophic factors of fetal origin has demonstrated a high recovery in activity in several experimental systems [107] [108] [109] . It was shown that rat pretreatment with FTC for 4 h before long-term (24-h) liver cold storage followed by reperfusion for 60 min led to a decrease in free radical production and normalization of antioxidant enzyme activity [110] . The pretreatment also had a positive effect on ATP level and restored the activity of a key ATP-generating enzyme of glycolysis, pyruvate kinase, as well as increasing the level of succinate-dependent mitochondrial respiration after short-term hypothermic storage [109] . Recently, Cherkashina et al. [111] showed that FTC presence in a sucrose-based cold preservation solution stabilized pro-oxidant-antioxidant balance, which is impaired in liver after hypothermic storage for 24 h followed by reperfusion, and prevented the uncoupling of mitochondrial oxidative phosphorylation and ATP level decline. In addition to the observed biochemical changes, supplementation of cold preservation solution with FTC resulted in almost complete restoration of bile flow rate during reperfusion and normal-DOI: 10.1159/000499610 ization of organ morphology. It is interesting that the natural cocktail of trophic factors contained in FTC demonstrated a more powerful protective effect on cold ischemia-induced liver injury than epidermal growth factor and IGF-1 added separately or in combination to UW solution [112] . The great protective potential of bioregulators of fetal origin as components of cold preservation solution enforces identification of individual bioactive molecules and investigation of their mechanisms of action.
Classification of Perfusion Techniques Based on Preservation Temperatures
In the history of perfusion machines, different strategies and temperatures of perfusion have been cited without consensus between authors. Terms such as hypothermic, subnormothermic, or normothermic were frequently used to describe perfusion temperatures, and the absence of a standardized criterion to describe technical details led to great heterogeneity between studies. In 2016, a group of distinguished researchers in the field of liver preservation proposed a nomenclature of perfusion temperature ranges that facilitates the comparison of different studies, meta-analysis realization, and criteria homogenization [113] . Much work in this area has focused on liver perfusion, although the same broad concepts apply to other organs.
Hypothermic Machine Perfusion (0-12 ° C)
Perfusion at this temperature range mainly reduces tissue metabolism and at the same time, through the preservation solution, provides the necessary metabolic substrates for ATP synthesis and removal of metabolic waste by washing the parenchyma and endothelium [114] . The proposed cutoff point for HMP at 12 ° C is supported by the observation of numerous energy-dependent reactions of mitochondrial liver enzymes which exhibit significant rate changes at this temperature [113] .
Accordingly, some of the benefits of HMP are minimization of cold ischemia injury, improvement of grafts viability, and protection against biliary lesions [115, 116] . In the case of hypothermic oxygenated perfusion, it also provides the opportunity to restore mitochondrial redox activity and cellular energy status while the metabolism is still dampened by hypothermia [117] . HMP additionally reduces the inflammatory response preventing Kupffer cell activation and decreasing neutrophils and platelets activity during reperfusion [118] and is considered a safe technique because, in the case of machine failure, the graft simply returns to the standard cold storage conditions. On the other hand, the main disadvantage of HMP is that assessment of liver function "in real time" is not feasible with this method. For instance, the liver does not synthesize bile during hypothermia [119] .
The first experience in humans was reported by Guarrera et al. [120] in 2010 with nonoxygenated hypothermic dual (portal vein and hepatic artery) perfusion of twenty standard donation after brain death (DBD) human livers. Twelve months after transplantation, the survival rate was 90%, early allograft dysfunction occurred only in 5% of the patients, and the incidence of biliary stricture was 5%.
Van Rijn et al. [121] tested dual hypothermic oxygenated machine perfusion over donation after cardiac death (DCD) livers. The biliary outcomes were also encouraging; none of the preserved livers required retransplantation for nonanastomotic biliary stricture, as opposed to 5 of 20 livers in the control group. In the largest HMP clinical trial performed, 50 recipients of extended DCD livers achieved superior outcomes compared with nonperfused DCD grafts and perfused DBD grafts [122] .
Midthermic Machine Perfusion (13-24 ° C)
In view of the fact that the broad range of temperatures, between 12 and 33 ° C, shows a great difference in the rate of metabolism, Karangwa et al. [113] considered more appropriate to subdivide this interval and proposed the term midthermic machine perfusion.
Midthermic and subnormothermic machine perfusion were proposed to achieve a balance between the deleterious effects of cold ischemia and the high metabolic requirements of normothermia [123] . Additionally, exposure of the graft to normothermic temperatures after a period of cold storage implicates a significant risk of oxidative stress burst.
The application of midthermic machine perfusion resulted in lower intravascular resistance, better conserved microcirculation, and stronger mitochondrial function, and these effects coincided with both a higher energy charge and bile production [119] .
Bruinsma et al. [124] examined the impact of a 3-h midthermic (21 ° C) perfusion on seven discarded livers. The grafts were gradually warmed, reaching the final temperature within 1 h. Liver function and dysfunction parameters showed not only that there was no liver injury, but also significantly improved liver functionality.
Subnormothermic Machine Perfusion (25-34 ° C)
Graft perfusion between 16 and 25 ° C is possible without the presence of red blood cells. It simplifies the procedure and could reduce costs. This is feasible because perfusion at subnormothermic temperature diminishes the activity of the respiratory chain in mitochondria and decreases the demand of cellular energy [125] .
In subnormothermic perfusion of pig livers, the hepatic and biliary injury was reduced in grafts harvested by DCD and steatotic livers [126] . In addition to the biliary improvements, lower serum levels of alkaline phosphatase were measured during the survival period in the group treated with subnormothermic machine perfusion compared with the control group. Improvement of the preservation protocols of marginal grafts has the potential to increase the donor pool and improve graft function after liver transplantation.
Controlled oxygenated rewarming is the most recent application of the perfusion machine, in which the perfusion begins at hypothermic temperatures and gradually increases to subnormothermia [127] , improving restitution of cellular homeostasis and mitigating rewarming injury by an adapted increase in temperature and metabolism [118] .
Controlled oxygenated rewarming has recently been applied clinically, with the successful transplantation of six DBD grafts accepted under "rescue allocation" criteria [128] . The controlled oxygenated rewarming group demonstrated a lower aspartate aminotransferase peak compared with controls and 100% of patient and graft survival at 6 months.
It is expected that subnormothermic ex vivo perfusion machines will play a cooperative role with other preservation techniques [129] . An example of this is the supercooling technique, which was used to preserve rat livers up to 96 h [130] . Supercooling was combined with subnormothermic machine perfusion [129] for the loading of cryoprotectants into the liver as well as postsupercooling rewarming. Prior to supercooling, researchers used subnormothermic perfusion to load isolated rat livers with a nonmetabolizable glucose derivative (3-O-methyl-D-glucose). Livers were supercooled avoiding intracellular ice formation and, at the end of supercooling, 3 h of subnormothermic perfusion was performed to achieve an adequate recovery period for the liver before orthotopic transplantation. The 3-month recipient survival in the group that received livers supercooled for 72 h at -6 ° C was 100%.
Normothermic Machine Perfusion (35-38 ° C)
The term normothermia usually refers to the physiological body temperature of the species used in the study, i.e., 37 ° C for human and rodent studies and 38 ° C in studies with porcine models. The idea underlying the technique is to replicate the normal metabolism of the liver outside the body, providing oxygen and essential substrates in an environment maintained at a normal temperature (37 ° C), avoiding ischemia and hypothermia altogether [119] . One of the main advantages of normothermic machine perfusion is the opportunity to evaluate the viability of the organ before its transplantation [118] by measuring markers of hepatic metabolism (i.e., bile production and liver enzymes release). The difficulty lies in providing sufficient oxygen and other necessary substrates to prevent subsequent graft deterioration and bacterial contamination, which is more likely to occur in warm environments [123] . Typically, perfusates based on concentrates of red blood cells, plasma, nutrients, cofactors and insulin, antibiotics, electrolytes and buffers are required, which makes normothermic machine perfusion a complex and expensive procedure [124] . To avoid the use of human blood products, the interest in extracellular oxygen carriers or oxygen-carrying plasma expanders has increased [131] .
The normothermic machine perfusion technology was initially developed to mitigate the negative effects of simple cold storage, but additional benefits have allowed its use for broader purposes [132] . Normothermic perfusion defatting seeks to augment the protective effect of perfusion by adding a pharmacologic "defatting cocktail" stimulating lipid metabolism. Use of a defatting cocktail reduced intracellular lipid content by 50% during 3 h of normothermic machine perfusion in steatotic rat livers [133] . Another additional benefit is the ability to extend the graft preservation times. In the first clinical series, Ravikumar et al. [134] demonstrated the feasibility of preservation over 20 h without compromising recipient outcome. Liu et al. [135] recently described the metabolic activity of a discarded human liver perfused for 86 h on ex situ normothermic machine perfusion. This is an important finding, since long-term preservation could provide an opportunity for tissue regeneration and organ reconditioning through pharmacological, immunological, and genetic interventions. As a demonstration of intact metabolism, bile production and lactate clearance were preserved until the end of 86 h. The hepatic histology of the parenchyma showed completely healthy hepatocytes. One limitation of the work, worthy of mention, was the absence of a transplant. Nasralla et al. [136] described the first multicenter randomized clinical trial in which normothermic perfusion was compared with SCS. A total of 170 livers were perfused in a normothermic machine and 164 preserved by SCS, and the authors reported the 1-year outcome for those successfully transplanted. There was a significant reduction in graft injury despite a 50% lower rate of organ rejection and a 54% longer mean preservation time. There was also no advantage to be gained from using normothermic perfusion in terms of any major outcome measure, such as graft or patient survival or frequency of biliary complications. Mergental et al. [137] reported liver transplants after a period of normothermic perfusion to assess the viability of the rejected livers. They used these livers after a variable period of cold storage and reported encouraging results, with an average hospital stay of 10 days and graft survival in all recipients.
It is probable that in the near future, normothermic perfusion will be used to change the concept of preservation, to a concept of being a method of treatment and repair of organs [138] .
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Experimental Observations of Temperature on Liver Preservation Perfusion Protocols
Liver hypothermic/midthermic/subnormothermic (H/M/S) perfusion effectiveness will depend on the following fundamental features: (1) Counteract cellular edema due to hypothermia: this phenomenon could be compensated by the inclusion of a cell impermeant substance into the perfusion solution [4] . (2) Prevent expansion of the interstitial space and subsequent compression of the vasculature that, during reperfusion, will generate an increase in intrahepatic resistance and vascular damage. With the inclusion of an oncotic active substance in the perfusion solution, it could be possible to control the water distribution between interstitial space and vasculature during perfusion [139] . (3) Provide adequate conditions for high-energy phosphate regeneration; therefore it will be possible to improve the function and viability of the liver during reperfusion. Accordingly, the addition of nucleotides and other substances into the perfusion solution could improve organ function and viability after the preservation procedure. (4) Supply an adequate gas atmosphere to obtain a lower oxidative metabolism, preventing the toxic effects of high oxygen concentrations in the perfusion solution [140] .
Specifically, colloid osmotic pressure (COP) or plasma oncotic pressure represents the counterforce to the filtration pressure in the blood circulation and is therefore partially responsible for the water distribution between the vasculature and the interstitial space [141] . Its physiological value is approximately 25 mm Hg and it was determined mainly by albumin concentration in the blood. For long-term perfusion experiments, oncotically active substances are essential to counteract interstitial edema, inevitably produced when these substances are not added to the perfusion solution.
COP could have effects on: (1 It is possible to ask: which is the optimal COP of a solution for H/M/S perfusion procedures? Since it is necessary to maintain an appropriate intravascular fluid level in presence of a lower perfusion pressure than the physiological one, it is important to consider the inclusion of a colloid in the hypothermic perfusion solution, for which the following experiments were carried out.
The COP (expressed in mm Hg) was determined using a colloidal osmometer or oncometer at 20 ° C ( Table 1) . The optimal condition would have been the determination of the COP at low temperatures, but this is not possible yet because commercial equipment is not available. However, a temperature correction could be made by using an appropriate formula if one were available.
COP Correction by Temperature
Nearly all publications indicate that the COP was determined at room temperature (20-25 ° C). Skillman and colleagues [142, 143] corrected this value to 37 ° C, based on the work of Soto-Rivera [144] , who used the Hepp osmometer to determine COP for comparison against plasma density.
The van't Hoff estimation for osmotic pressure is π = CRT where C is the molar solute concentration, R is the ideal gas constant, and T is the absolute temperature (Kelvin). Then the effect of the variable temperature could be calculate as:
in which π calculated and π measured represent the calculated and measured values, respectively, for π at their corresponding temperatures in ° C. If a COP determined at 20 ° C is 11.3 mm Hg, then the value at 5 ° C will be calculated as In the following example, determinations were done by using an OSMOMAT 050 oncometer from GONOTEC with a semipermeable membrane of 20,000 Daltons cutoff.
Our group has been interested in developing a new group of OPS formulated on gluconate and the Good's buffer BES (N,N-bis[2-hydroxyethyl]-2-aminoethanesulfonic acid) with different colloids (e.g., BES gluconate HES-BG-HES [145] ). Their physicochemical properties have been studied and compared with other traditional OPS [79] . Experimental COP values obtained for the newly formulated gluconate-based BG-PEG and BG-HES preservation solutions [145] were determined at different concentrations of two different colloids: PEG 35000 and HES used at 1, 2, 5, 10, and 20 g/L at 20 ° C. The results are presented in Figure 2 .
At a similar colloid concentration, the COP developed by the PEG 35000 is higher than that of HES. In fact, using the obtained equations, it is possible to calculate the colloid concentration and obtain an appropriate COP in the perfusion solution.
Theoretical Calculations to Determine the Appropriate Concentrations of Colloidal Substances Which Produce COP Suitable for an H/M/S Perfusion Solution
Based on the classical Starling equation, the purpose of this study was to obtain an accurate and simple method for calculating the COP concentration to apply in an H/S protocol. We based this calculation on the graphic shown in Figure 2 . These graphs were obtained plotting the COP measured at different concentrations of oncotic substances, such as PEG 35000 and HES, in BG-basic perfusion/preservation solutions at 20 ° C.
The classical Starling hypothesis [146] can be expressed as:
where F is the capillary filtration, K f is the membrane permeability component, P is the hydrostatic pressure, π is the COP, c is capillary, pl is plasma, and isf is interstitial fluid. As was reported by Weisberg [141] , the systemic capillary forces could be represented in a simplified frame, as shown in Table 2 .
If we consider a hypothermic perfusion protocol in which the perfusion pressure is 25% lower (4.2 mm Hg) than the physiological one, the calculated outward flow will be 15.3 mm Hg (see hypothermic perfusion protocol in the frame). Then we should provide an oncotic substance that in the perfusion solution achieves a COP of 15.0 mm Hg.
The equation corresponding to PEG 35000 added into BG-basic solution shown in Figure 2 In order to compare BGP-HMP with other traditional preservation solutions [79] , such as HTK [79, 147] , BGP- CS [147] , and Viaspan ® (UW solution) [4, 79] , we determined different physicochemical parameters: COP (mm Hg), osmolality (mOsm/kg H 2 O), and viscosity (cP) of the solutions (Table 1) . Solution compositions are shown in Table 3 .
Using the theoretical calculations expressed above, it is possible to determine the appropriate PEG or HES concentration which produces a suitable COP for hypothermic protocols.
Although hypothermic perfusion protocols are designed to recreate a physiological environment, this model is quite far from the normal physiology of an organ. For example, hypothermic perfusion differs from physiological perfusion in the following points: (1) The perfusion pressure is only 25% of the normal pressure (40 vs. 180 mm H 2 O) [148] . (2) The procedure of hypothermic perfusion is maintained at a temperature of 5 ° C. (3) At that temperature, the consumption of O 2 by the tissue is approximately 5% of the physiological requirement at 37 ° C [149] . Point 3 involves a controversy not yet resolved, namely the appropriate oxygen concentration in an H/M/S perfusion solution. It will be necessary to establish the oxygen consumption by the organ with the perfusion protocol used to assure the correct gas concentration at the flow and pressure utilized. This research involves (1) the oxygen solubility in the perfusion solution at the perfusion temperature and (2) the organ oxygen consumption at the perfusion temperature.
Solubility curves of O 2 at different temperatures in BGP-HMP (Fig. 3A) and HTK ( Fig. 3B ) solutions were experimentally determined as previously reported [150] .
In previous experiments, a lower oxygen consumption from hypothermically perfused rat livers was reported [149] . The O 2 consumption of isolated rat livers perfused at 5 and 10 ° C with BGP-HMP or HTK solutions saturated with air was also established [151] . It is necessary to provide appropriate oxygenation of the preservation solution during HMP perfusion protocols as a requirement for effective preservation and maintenance of organ viability and function.
Experimental Observations about the Viscosity of the Perfusion Solutions at Low Temperatures
Viscosity is a measure of the resistance of flow due to internal friction of a fluid. Owing to viscosity, it is necessary to apply a force when one layer of fluid is caused to move in relationship to another layer.
When the internal flow resistance is independent of the external force, as is the case with water, the fluid is called a Newtonian fluid. In the case of non-Newtonian fluids, they change viscosity when exposed to different Temperature strongly influences the fluid's viscosity. The viscosity of blood at 4 ° C is double that at 37 ° C [152] . In the liver, vascular resistance correlated well with the viscosity of the perfused fluid. In addition, the concentration of the oncotic agent contained in the preservation solution strongly affects its viscosity. It was shown that in static preservation procedures, the viscosity of the initial flushing solution may play an important role in determining the outcome of organ procurement from nonheart-beating donors [153] . It was reported that HES in UW preservation solution affects the organ washout due to red blood cell aggregation [152] . Livers flushed with solutions of low viscosity showed lower vascular resistance than those flushed with cold UW solution, and this improved the viability of the organ.
When considering preservation perfusion procedures such as H/S perfusion, the effects of temperature on fluid viscosity have not been rigorously investigated. For these reasons, it is important to study the results of this combination of effects on solution viscosity and how this affects 4 -is both anion and buffer. ** Lactobionate is an anion with calcium chelation properties. *** N-acetyl histidine is an osmolyte and intracellular buffer. # For composition, see Figure 4B . ## organ outcome after preservation. To achieve this, the experimental results of different temperatures on viscosity of BG-basic preservation solution at different PEG concentrations are needed.
The BG-basic solution has the same chemical composition as BGP-HMP solution without oncotic agents (Fig. 4) . We also determined the effect of adding HES to the BG-basic solution at different temperatures. Experimental results were obtained with a rotational digital viscosimeter (LCD Shanghai Nirun Intelligent Technology, model SNB-2).
The BGP-HMP solution was developed for hypothermic perfusion [145] and also tested for static preservation [147] , the oncotic agent used was PEG 35000 at a concentration of 1 g/L. Figure 4 shows the effect of temperature on BG-basic solution viscosity at different PEG concentrations. A decrease in temperature exponentially increases the viscosity of the solution; this effect is magnified by the raise in PEG concentration. Interestingly, the substitution of PEG by HES increases the viscosity of the preservation solution with a temperature reduction, but this increase in concentration does not affect the viscosity in the same way as PEG. Finally, we compared similar concentrations of both compounds (PEG and HES) at low temperatures; PEG 35000 viscosity was significantly higher than HES viscosity. Figure 4 shows the comparison of the effect of temperature on the viscosity of the preservation solutions UW, HTK, BGP-HMP, BGP 35, and water.
In cold storage preservation, the role of the preservation solution viscosity becomes essential during organ washout to enable its distribution through the vasculature of the entire organ, preventing the effects of cold ischemia. However, in H/S perfusion techniques, where long perfusion times and good performances of the organ vasculature are required, the viscosity of the perfusion solution is associated with the concentration of the oncotic agent in a delicate balance between the control of interstitial edema and the perfusion flow and vascular resistance. 
Analyzing Perfusion Parameters in the Preservation of Organs
New technologies that are being developed in organ perfusion, which involve new roller pumps, new blood gas exchange devices, new centrifugal heads, miniaturized devices, and of course the development of the perfusion training programs mainly during the past 20 years, have led to the scientific evolution of perfusionists and to the development of these techniques. Ultimately, these new technologies are trying to create an appropriate environment to preserve the organ in the best possible way, outside of its usual environment, and maintain this situation until the organ is implanted. However, many debates still remain, dealing with the ways of achieving the optimal perfusion, but mainly with the relationship between perfusion pressures and the optimal preservation solution flow during extracorporeal circulation [154] . For instance, roller pumps by their design produce a pulsatile wave pattern of flow, which by producing the appropriate pulsatile wave could serve to overcome the opening pressure for the capillary bed, sufficient to allow brief but ongoing "bursts" of perfusion, whilst avoiding continuous exposure to this higher pressure, which is recognized as a contributing factor to develop a deleterious tissue edema [140] .
Improvements in OPS continue to be made with new pharmacological approaches. New solutions have been developed for dynamic perfusion preservation and are now in clinical protocols [79] . The basis of this hypothermic protection is that cooling can help combat the deleterious effects of ischemia, but the consequences of cooling are not exclusively beneficial. Hypothermic storage is a compromise between the benefits and detriments of cooling [155] . Preservation advances allow the use of perfusion circuits to mimic healthy physiological conditions, which was originally presented by Downes et al. in 1973 [156] . This was based on the hypothesis that organs are best preserved in a condition as physiological as possible, by providing oxygen together with sufficient nutrients to support a constant metabolism. Initially, this preservation was conducted at body temperature. Only later was the development of hypothermia and SCS introduced, where the organ was cooled in vivo through a flushout with a cold preservation solution and subsequently stored on ice [157] . Inside this paper, Vekemans et al. compiled an interesting list of references related to pressure, flows, species, and temperature during hypothermic perfusion or normothermic machine perfusion. These actions permit the organ to recover from cellular stress and tissue injury during donor death and organ procurement, which can contribute to organ injury and rejection following transplantation, and also enable therapeutic intervention before transplantation. The advent of ex vivo organ perfusion shows promise to make larger pools of donor organs available by enabling rehabilitation of organs that would otherwise be unsuitable for transplantation [158] .
The other potential risk for organs exposed to continuous oxygenation at low temperatures during hypothermic perfusion is production of oxygen-derived free radicals with consequent cell damage, either because abnormally high oxygen tensions may be used by deliberate oxygenation of the perfusate, or because the normal antioxidant defenses, depending on consumption and regeneration of antioxidants, are disrupted at low temperatures [140] .
Warm Perfusion
If one accepts the overall premise that perfusion of organs is a valuable approach to maintaining function, the obvious question is: why use low temperatures? Why not perfuse at normal body temperatures and avoid the metabolic challenge of cooling?
From the preceding sections, it will have become apparent that normothermic conditions were applied early in the history of in vitro organ perfusion, but the challenges of providing good oxygen carrying (using blood or blood components) without encountering problems of thrombus formation, vascular damage, and infection were insurmountable with the technology available at the time. A major concern when applying warm perfusion has been to supply not only sufficient oxygen-carrying capacity to support aerobic metabolism, but in addition all the other physiological mediators (the various substrates and cofactors) which are required for regulated homeostasis in the isolated organ. In some ways this can be considered analogous to the complex media developed for cell culture in vitro. Viewed from a different perspective, no advantage would be achieved from using a warm perfusion system, which induced early signaling markers for stress or inflammatory processes. The various components of normal blood provide the ideal perfusate for warm perfusion, but require sophisticated technology to maintain oxygenation and adequate intravascular flow, without inducing activation of circulating blood cells, microthrombi, and associated negative effects on organ microcirculation (a situation in some ways analogous to cardiopulmonary bypass). To replace blood with a cell-free synthetic solution poses different but equally difficult questions about reproducing the complete range of blood functions [140] .
Summary and Future Horizons
Almost a decade has passed since our UNESCO Chair grouping reviewed how organ preservation was then being practiced and what research areas were potentially DOI: 10.1159/000499610 signposting new possibilities for clinical translation [80] . Organ perfusion was just re-establishing itself as a valuable clinical option for ex vivo preservation, after many years in which it had not been considered mainstream. Now, dynamic intervention by continuous perfusion is one of the most-discussed topics at transplantation meetings, with different systems and ranges of temperatures being applied in trials in all the major organ classes. These in turn are raising exciting possibilities for organ conditioning or repair as novel therapies during the perfusion period, which may well become a "hot topic" for research over the next 10 years. The concept of true long-term organ preservation at deep sub-zero temperatures also seemed to be at an impasse in previous times [80] , whereas now there are small signs of renewed interest and investigation [129, 159, 160] , although these currently remain far from clinical application. In turn, they will depend on new kinds of dynamic perfusion. Perhaps these will be accelerated towards translation by new ideas and better understanding of the underpinning scientific principles by studies in cryobiology. Whichever technologies become predominant, the times ahead will certainly be very interesting in the quest to develop better organ preservation strategies and understand the cell and molecular changes in organs outside the body, which form the "supply line" for clinical transplantation.
